TrialJournal of Korean medical science2017

Outcome of Reinduction Chemotherapy with a Modified Dose of Idarubicin for Children with Marrow-Relapsed Acute Lymphoblastic Leukemia: Results of the Childhood Acute Lymphoblastic Leukemia (CALL)-0603 Study.

Kyung Nam Koh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.